U.S. Pharma Stock News

Marqeta (MQ) is back in focus after its fourth quarter 2025 update, which paired higher reported sales and a sharply smaller net loss with fresh 2026 guidance on revenue and gross profit growth. See our latest analysis for Marqeta. Marqeta’s earnings update and 2026 guidance have arrived after a softer patch in the stock. The 7 day share price return of 4.88% contrasts with a 90 day share price return of negative 15.35% and a 3 year total shareholder return of negative 3.09%. This suggests...

Occidental Petroleum (OXY) is back in focus after it expanded the size of its cash tender offers to repurchase up to US$1.2b of outstanding notes and secured key bondholder consents. See our latest analysis for Occidental Petroleum. Occidental’s expanded tender offer and strong early bondholder participation come as the share price trades at US$55.02, with a 30 day share price return of 18.81% and year to date share price return of 29.83%. The 5 year total shareholder return of 100.16%...

Recent share performance and what it means for investors Hercules Capital (HTGC) has drawn investor attention after a recent pullback, with the stock showing negative returns over the past month and past 3 months, alongside a weaker move over the past year. At a last close of US$14.67, Hercules Capital sits below its recent levels. Returns of 76.11% over 3 years and 53.64% over 5 years provide a longer term contrast to its shorter term performance. See our latest analysis for Hercules...

What ResMed’s new Greenwood hub could mean for the stock ResMed (RMD) is opening a new distribution center in Greenwood, Indiana, planned to start operations in 2027. The facility is intended to improve delivery coverage and speed for its sleep and respiratory care products across North America. See our latest analysis for ResMed. At a share price of US$252.93, ResMed has had a softer patch recently with a 30 day share price return of a 6.88% decline, even though its 1 year total shareholder...

Why Kymera’s latest update matters for shareholders Kymera Therapeutics (KYMR) has put several big items on the table at once, including a planned US$500 million at the market equity offering, wider quarterly and full year losses, and a new Chief Development Officer. These moves come as the company continues to invest in its protein degradation pipeline, and they raise practical questions for you around dilution, funding flexibility, and how leadership changes might influence the pace and...

Leadership shift and upcoming conference draw attention to Capri Holdings stock The recent decision by Capri Holdings (CPRI) to appoint Tyler Reddien as both Chief Financial Officer and Chief Operating Officer, along with an upcoming appearance at Citi’s 2026 Global Consumer & Retail Conference, has brought fresh attention to the stock. See our latest analysis for Capri Holdings. Capri Holdings' share price has softened over the past year, with a 30 day share price return of a 9.22% decline...

Belite Bio, Inc reported fourth-quarter and full-year 2025 results, with net loss widening to US$25.32 million for the quarter and US$77.61 million for the year, compared with US$10.1 million and US$36.14 million respectively in the prior periods. The company is now absorbing materially higher per-share losses as it scales R&D and commercial infrastructure ahead of potential Tinlarebant approvals in rare retinal diseases. We’ll now examine how Belite Bio’s significantly wider 2025 net loss...

In late February 2026, Willis Towers Watson reported fourth-quarter 2025 results that beat expectations, expanded operating margins, and approved a regular quarterly cash dividend of US$0.96 per share, a 4% increase from the prior quarter. Alongside these results, WTW created new leadership roles and launched a Global Digital Infrastructure Group, highlighting its push into specialized, cross-functional risk solutions for data center and digital infrastructure clients. Now we’ll examine how...

Why National Fuel Gas is on investors’ radar National Fuel Gas (NFG) has drawn fresh attention after recent share price moves, with the stock showing double digit total returns over the past 3 months and year. This performance has prompted closer scrutiny of its fundamentals. See our latest analysis for National Fuel Gas. Recent trading has been relatively steady, with a 30 day share price return of 8.3% and a 90 day share price return of 13.4%. The 1 year total shareholder return of 28.2%...

In February 2026, Millicom International Cellular S.A. reported fourth-quarter 2025 sales of US$1,652 million and net income of US$252 million, with basic earnings per share from continuing operations rising to US$1.51. For full-year 2025, Millicom’s net income increased to US$1.32 billions on essentially unchanged sales of US$5.82 billions, highlighting a sharp improvement in profitability relative to revenue growth. We will now examine how this surge in full-year profitability might...

In recent days, Trane Technologies faced pressure after going ex-dividend amid concerns that its shares are trading at a premium to industry peers, while an executive’s share sale added to questions about near-term confidence. At the same time, the company advanced its sustainability agenda with new climate-smart cooling programs in India and Africa and launched an energy-efficient chiller tailored for Asia Pacific data centers, underscoring its push into high-demand, lower-emission cooling...

Why Tripadvisor Is Back in Focus Investor worries about artificial intelligence cutting out online travel intermediaries have eased after reports that OpenAI will lean on existing booking platforms instead of handling reservations directly inside ChatGPT. For Tripadvisor (TRIP), that shift, combined with its 2026 update to a more heavily weighted review system that factors in recency, volume, and fraud detection, has pushed attention back to the quality of its travel guidance and how it...

Diversified Energy (DEC) has moved to raise fresh capital by completing a roughly US$108.4m follow-on equity offering and filing an omnibus shelf registration that covers common stock, preferred stock, warrants and units. See our latest analysis for Diversified Energy. The follow on offering comes after a run of company updates, including 2025 earnings, new production guidance for 2026, a fresh share buyback authorization and an acquisition agreement in East Texas. It arrives as the share...

D-Wave Quantum (QBTS) is back in focus after its fourth quarter and full year 2025 earnings, where revenue and losses moved in different directions and raised fresh questions about risk and opportunity. See our latest analysis for D-Wave Quantum. Since those earnings, investors have been wrestling with mixed signals, and the stock reflects that: despite a 1-day share price return of 2.42%, the 90-day share price return of negative 32.79% contrasts sharply with a very large 1-year total...

State Street (STT) is back in focus after a weak February jobs report triggered a 3.1% share price decline, as investors reassessed credit risk and potential pressure on investment activity across financial stocks. See our latest analysis for State Street. That 3.1% drop after the weak jobs report came on top of recent pressure, with a 7 day share price return of 5.82% and a 30 day share price return of 7.87%. However, the 1 year total shareholder return of 44.68% and 3 year total shareholder...

Cencora recently reported fiscal first-quarter 2026 adjusted earnings per share of US$4.08, slightly above estimates and 9.4% higher year over year, and raised its full-year guidance for revenue and adjusted operating income while declaring a US$0.60 quarterly dividend. Shareholders reinforced board continuity and executive direction at the 2026 Annual Meeting, as Cencora continues expanding in specialty distribution and European markets while addressing higher expenses and an impairment in...

Earnings driven move in Teradyne (TER) Teradyne (TER) is back in focus after its Q4 2025 earnings topped expectations, with US$1.083b in revenue, largely driven by Semiconductor Test demand for AI, compute, networking, and memory. See our latest analysis for Teradyne. The strong Q4 report and AI driven Semiconductor Test demand have come alongside sharp price swings, with an 8.6% 1 day share price return, a 48.2% 90 day share price return, and a very large 1 year total shareholder return of...

In early March 2026, Semtech announced that its LoRa technology will remain the core radio modulation for Amazon Sidewalk as the network moves from covering about 95% of the U.S. population to a phased international rollout starting in Canada and Mexico and extending to additional regions this year. This deepening role within one of the largest consumer-facing LoRa deployments globally, alongside a new Trident IoT agreement for multi-protocol smart home solutions, underscores how Semtech’s...

In early March 2026, United Therapeutics announced that its long-term pivotal phase 3 ADVANCE OUTCOMES study of ralinepag in pulmonary arterial hypertension met its primary and key secondary endpoints, and the Board authorized a one-year US$2.00 billion share repurchase program including accelerated buybacks. Together, the robust late-stage data for ralinepag and the large, time-bound buyback highlight how United Therapeutics is pairing pipeline progress with capital returns to...

In February 2026, RXO, Inc. launched its Middle Mile Solutions service, offering an integrated "dock-to-door" logistics network that links first-, middle-, and last-mile transportation with warehousing, kitting, and reverse logistics, all powered by its RXO Connect® tech platform for item-level visibility and proactive alerts. This move effectively positions RXO as a single-source logistics partner for shippers seeking to simplify vendor relationships while tightening control over complex,...

Resideo Technologies reported past fourth-quarter 2025 results with sales of US$1,895 million and net income of US$136 million, alongside full-year 2025 sales of US$7.47 billion but a net loss of US$527 million. The company also issued 2026 guidance calling for net revenue of US$1,866 million to US$1,890 million in the first quarter and US$7.80 billion to US$7.90 billion for the full year, highlighting a contrast between recent quarterly profitability and a loss-making full year. Against...

RB Global, Inc. recently announced that its Board of Directors has authorized a share repurchase program of up to US$500,000,000, subject to Toronto Stock Exchange approval and funded through cash reserves or its senior credit facility. This sizable buyback authorization, coming alongside strong quarterly results that exceeded analyst expectations, highlights management’s confidence in deploying capital to support shareholder value. We’ll now examine how the newly authorized US$500,000,000...

Event context and recent share performance Arcos Dorados Holdings (NYSE:ARCO), the master franchisee for McDonald’s across Latin America and the Caribbean, has recently seen mixed share performance, with a small 1 day gain alongside a decline over the past week. Over the past month, the stock shows a 6.4% decline, while the past 3 months reflect a 9.9% gain and the 1 year total return stands at 4.5%, giving investors a mixed recent track record to weigh. See our latest analysis for Arcos...

Signet Jewelers recently released preliminary fourth-quarter and full-year fiscal 2026 results, highlighting sequential improvement in comparable sales and solid momentum during peak holiday trading, alongside plans to outline fiscal 2027 guidance. An interesting angle for investors is management’s expectation of generating more than US$500 million in free cash flow in fiscal 2026, supported by operational performance and working capital discipline. We’ll now look at how the company’s free...